Patents for C40B 30 - Methods of screening libraries (11,320)
01/2012
01/26/2012CA2806310A1 Methods of detecting diseases or conditions using phagocytic cells
01/26/2012CA2806302A1 Methods of detecting neurological or neuropsychiatric diseases or conditions
01/26/2012CA2806301A1 Methods of detecting cardiovascular diseases or conditions
01/26/2012CA2806296A1 Methods of detecting kidney-associated diseases or conditions
01/26/2012CA2806293A1 Methods of detecting autoimmune or immune-related diseases or conditions
01/26/2012CA2806291A1 Methods for detecting signatures of disease or conditions in bodily fluids
01/26/2012CA2802111A1 Identification of differentially represented fetal or maternal genomic regions and uses thereof
01/24/2012CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
01/19/2012WO2012009704A2 Novel peptides and uses thereof
01/19/2012WO2012009568A2 Antibody libraries
01/19/2012WO2012009554A2 Methods and systems for in vivo clinical data measurement of analytes
01/19/2012WO2012009394A2 Methods to identify combinations of ns5a targeting compounds that act synergistically to inhibit hepatitis c virus replication
01/19/2012WO2012006730A1 Diagnostic method for colitis
01/19/2012WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses
01/19/2012US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer
01/19/2012US20120016000 Method to assay phospholipid and triglyceride transfer activity of microsomal triglyceride transfer protein
01/19/2012US20120015906 Uses of bortezomib in predicting survival in multiple myeloma patients
01/19/2012US20120015904 Biomarkers for diagnosis of transient ischemic attacks
01/19/2012US20120015878 Use of adnf polypeptides for treating anxiety and depression
01/19/2012US20120015847 Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3
01/19/2012US20120015846 Label-free Cellular Pharmacology For Drug Antitarget Assessment
01/19/2012US20120015845 Markers for the diagnosis of aml, b-all and t-all
01/19/2012US20120015844 Device and method for producing a replicate or derivative from an array of molecules, and applications thereof
01/19/2012US20120015843 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
01/19/2012US20120015842 Enumeration Of Nucleic Acids
01/19/2012US20120015841 Novel cell lines and methods
01/19/2012US20120015840 Methods for generation of rna and (poly)peptide libraries and their use
01/19/2012US20120015839 Recurrent gene fusions in cancer
01/19/2012US20120015838 Method and Kit for Diagnosing Autism Using Gene Expression Profiling
01/19/2012US20120015837 Method for diagnosing endometrial cancer
01/19/2012US20120015836 Kits for multiplexed nucleic acid analysis by capture of single-stranded dna produced from double-stranded target fragments
01/19/2012US20120015835 Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles
01/19/2012US20120015834 Methods for artificial combinatorial control of biological systems
01/19/2012US20120015833 Method and apparatus for detecting molecules
01/19/2012US20120015832 Methods, panels of identification markers, and kits for identifying forensic samples
01/19/2012US20120015831 Method for delivering nucleic acid into eukaryotic genomes
01/19/2012US20120015830 Microrna profiles for evaluating multiple sclerosis
01/19/2012US20120015829 Adaptive Immunity Profiling and Methods for Generation of Monoclonal Antibodies
01/19/2012US20120015828 Sample analysis chip, sample analyzer using sample analysis chip, sample analysis method, and method of producing sample analysis chip
01/19/2012US20120015827 Method for therapy prediction in tumors having irregularities in the expression of at least one vegf ligand and/or at least one erbb-receptor
01/19/2012US20120015825 Analytical systems and methods with software mask
01/19/2012US20120015824 Method For Diagnosing Allergic Reactions
01/19/2012US20120015821 Methods of Generating Gene Specific Libraries
01/19/2012US20120015819 Mixture of at least two fusion proteins, the production thereof and the use of the same
01/19/2012US20120015049 Microrna biomarker in cancer
01/19/2012US20120014993 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures
01/19/2012US20120014940 Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies
01/19/2012US20120014870 Diagnosis and Treatment of Cancer Using Anti-LGR7 Antibody
01/19/2012CA2805875A1 Antibody libraries
01/19/2012CA2805306A1 Diagnostic method for colitis
01/19/2012CA2805249A1 Methods and systems for in vivo clinical data measurement of analytes
01/12/2012WO2012006589A2 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
01/12/2012US20120010274 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
01/12/2012US20120010266 Tbc1d7 as tumor marker and therapeutic target for cancer
01/12/2012US20120010240 CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR
01/12/2012US20120010230 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
01/12/2012US20120010105 Label-free high throughput biomolecular screening system and method
01/12/2012US20120010104 Growth selection method
01/12/2012US20120010103 Methods of screening using amphibians
01/12/2012US20120010102 Modulation of abcg2-mediated urate transport to treat hyperuricemia and gout
01/12/2012US20120010101 Novel triple tag sequences and methods of use thereof
01/12/2012US20120010100 Plant farnesyltransferases
01/12/2012US20120010099 Diagnostic markers of wound infection
01/12/2012US20120010098 Selection by compartmentalised screening
01/12/2012US20120010097 Microchannel, and nucleic acid hybridization microchip, column, system and method
01/12/2012US20120010096 Methods and compositions for diagnosing and monitoring transplant rejection
01/12/2012US20120010095 Methods for diagnosis and prognosis of pulmonary hypertension
01/12/2012US20120010094 Detecting and monitoring left ventricular hypertrophy and congestive heart failure by profiling biomarkers
01/12/2012US20120010093 Apparatus and methods for detecting nucleic acid in biological samples
01/12/2012US20120010092 Methods for Identifying Fragile Histidine Triad (FHIT) Interaction and Uses Thereof
01/12/2012US20120010091 Gene expression analysis in single cells
01/12/2012US20120010090 Method of diagnosing breast cancer
01/12/2012US20120010089 Pcr-based detection method for chlamydia trachomatis
01/12/2012US20120010088 Gel having biosubstance fixed thereto and microarray utilizing the gel
01/12/2012US20120010087 Methods for Genotyping
01/12/2012US20120010086 Clonal pre-amplification in emulsion
01/12/2012US20120010085 Methods for determining fraction of fetal nucleic acids in maternal samples
01/12/2012US20120009570 Restoration of Nucleic Acid From Degraded or Formalin-Fixed and Paraffin-Embedded Tissue and Uses Thereof
01/12/2012US20120009201 Renal cell carcinoma biomarkers
01/12/2012US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof
01/12/2012US20120009177 Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
01/12/2012DE102011101888B4 Screeningverfahren mit Mikroarrayformat für Reinigungsmittel-Stoffbibliotheken Screening methods, microarray format for detergent compound libraries
01/12/2012DE102007006736B4 In-vitro Testkit zur tierversuchsfreien Bestimmung des sensibilisierenden Potentials einer Substanz In vitro test kit for animal-free determination of the sensitizing potential of a substance
01/12/2012CA2804218A1 Detection of target metabolites
01/12/2012CA2801110A1 Lung cancer biomarkers and uses thereof
01/05/2012WO2012000119A1 A method of determining a predisposition to atrial fibrillation in a subject
01/05/2012US20120005766 Methods of identifying agents that modulate phenotypes related to disruptions, of a gene encoding PRO235 polypeptide
01/05/2012US20120004289 Annexin a11 and associated genes as biomarkers for cancer
01/05/2012US20120004278 Linc rnas in cancer diagnosis and treatment
01/05/2012US20120004205 Il-13 induced gene signature for eosinophilic esophagitis
01/05/2012US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
01/05/2012US20120004138 Electrophoresis apparatus for simultaneous loading of multiple samples
01/05/2012US20120004137 Identification of nucleic acid delivery vehicles using dna display
01/05/2012US20120004136 Msh2 and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer
01/05/2012US20120004135 Identification of biologically and clinically essential genes and gene pairs, and methods employing the identified genes and gene pairs
01/05/2012US20120004134 Diagnostic Assay For Source of Inflammation
01/05/2012US20120004133 Method for the diagnosis of age-associated vascular disorders
01/05/2012US20120004132 Detection of Nucleic Acids and Proteins
01/05/2012US20120004131 Microarrays and uses therefor
01/05/2012US20120004130 Autoimmune disease biomarkers
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 114